A study suggests that patients with wet AMD may regain vision through a novel approach — removing abnormal blood vessels and ...

The data was included in the paper, titled “Sozinibercept Combination Therapy for Neovascular Age-Related Macular ...

Outlook Therapeutics has re-submitted its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) ...

Age-related macular (AMD) degeneration is a leading cause of vision impairment and blindness in the elderly population.

Baseline angiographic lesion characteristics predictive of clinical responsePublished in peer-reviewed journal Ophthalmic Surgery, Lasers and ...

At the Envision Summit 2025 in San Juan, Puerto Rico, Giulia Corradetti, MD discussed AI applications in the identification ...

The Macula Society is a forum for new research in retinal vascular and macular diseases. David S. Boyer, MD will present data from the sozinibercept Phase 2b wet AMD trial demonstrating that ...

Brolucizumab stabilizes retinal exudation and fluid, improving visual outcomes in wet AMD management ... and to spectral-domain optical coherence tomography (SD-OCT) imaging.

Although AI shows significant promise in diagnosing and managing age-related macular degeneration, its efficacy is reduced by bias, data quality and limited generalizability, according to a review ...

Optical coherence tomography (OCT): Uses imaging to ... to highlight abnormal blood vessels in the retina (used mainly for wet AMD diagnosis). While there is no cure for AMD, treatments can ...